Tumori Journal – Author's Insight A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
1 tracks • 0 plays • 0 favorites
Tumori Journal – Author's Insight A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
Andaaz Suhan
0:006:47
Knowledge
Episodes
1
Tumori Journal – Author's Insight A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
Andaaz Suhan